These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4178461)

  • 1. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions.
    Beall G; Doniach D; Roitt I; el Kabir D
    J Lab Clin Med; 1969 Jun; 73(6):988-99. PubMed ID: 4977698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
    Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
    Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
    Berumen FO; Lobsenz IL; Utiger RD
    J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 7. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P; Smith BR; Munro DS
    Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
    Brown J; Ensor J; Munro DS
    Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids.
    Field JB; Remer A; Bloom G; Kriss JP
    J Clin Invest; 1968 Jul; 47(7):1553-60. PubMed ID: 5658587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LATS and thyroid autoantibodies.
    Beall GN; Solomon DH
    Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 15. REDUCTION OF GAMMA GLOBULIN WITH LONG-ACTING THYROID-STIMULATING ACTIVITY.
    DORRINGTON KJ; MUNRO DS; CARNEIRO L
    Lancet; 1964 Oct; 2(7365):889-91. PubMed ID: 14197190
    [No Abstract]   [Full Text] [Related]  

  • 16. LATS inhibition by a soluble lipoprotein from human thyroid gland.
    Chopra IJ; Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1971 Jun; 32(6):772-8. PubMed ID: 5577160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract]   [Full Text] [Related]  

  • 18. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F; Schleusener H; Uher L; Ananos A
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.